SIGASIGA Technologies, Inc.
4.710USD+0.64%Mkt Cap: 336.03M USDP/E: 16.73Last update: 2026-05-26

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox d…

Indicators:|

Key Statistics

Company
Market Cap336.03M USD
Enterprise Value192.86M USD
Revenue (TTM)93.78M USD
Gross Profit64.87M USD
Net Income (TTM)23.28M USD
Revenue/Share1.310 USD
Last Price4.710 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)16.73
P/E (Forward)4.49
PEG3.37
EV/EBITDA9.09
EV/Revenue2.06
P/S3.60
P/B1.70
EPS (TTM)0.28
EPS (Forward)1.05
52W Range
4.10011% of range9.620
52W High9.620 USD
52W Low4.100 USD
Profitability
Gross Margin68.59%
Oper. Margin-85.24%
EBITDA Margin22.62%
Profit Margin24.61%
ROE11.71%
ROA10.61%
Growth
Revenue Growth-11.30%
Earnings Growth
Cash Flow & Leverage
Operating CF43.47M USD
CapEx (TTM)355.01K USD
FCF Margin63.39%
FCF Yield17.69%
Net Debt-144.96M USD
Net Debt/EBITDA-6.83
Balance Sheet
Debt/Equity0.00
Current Ratio3.25
Quick Ratio2.30
Book Value/Sh2.776 USD
Cash/Share2.029 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateApr 7, 2026
Pay DateApr 23, 2026
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.71.72M
Float41.12M
Insiders42.66%
Institutions49.63%
Short Interest
Short Ratio5.1d
Short % Float7.19%
Short % Out.4.65%
Shares Short3.34M
Short (prev mo.)3.48M
Technical
SMA 504.743 (-0.7%)
SMA 2006.713 (-29.8%)
Beta0.85
S&P 52W Chg28.31%
Avg Vol (30d)508.75K
Avg Vol (10d)681.98K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)